A New Perspective on Psychedelics
There is a growing body of evidence that psychedelic drugs can be used to treat a variety of medical conditions. Should they be considered for wider use?
LSD, magic mushrooms, mescaline, peyote - just some of the most well known psychedelic drugs. Most of them are illegal around the world. Research into psychedelic medicine was virtually shut down in the West because psychedelics were considered mind-altering substances open to abuse. This perception is changing. There is a growing body of evidence that some psychedelic drugs can be used to treat a variety of medical conditions. There have been clinical trials of psilocybin - the active ingredient in magic mushrooms - for treatment-resistant depression. Just one dose was found to help people with life-threatening cancer face death. James Coomarasamy and a panel of expert guests discuss the evidence that psychedelics have transformative and beneficial properties. Are most authorities right to continue to ban them or should they be considered for wider use - and if so, under what conditions?
Last on
More episodes
Contributors
Rosalind Watts - Clinical psychologist, Imperial College London
Amanda Feilding - Oxford based psychedelics researcher
Mo Costandi - Freelance science writer
David Nichols - Professor at University of North Carolina at Chapel Hill
Photo
AΒ healer starting a ceremony with the psychedelic, yage, in La Calera, Colombia by Eitan Abramovich/AFP/Getty Images
Broadcasts
- Fri 24 Aug 2018 08:06GMTΒι¶ΉΤΌΕΔ World Service except News Internet
- Fri 24 Aug 2018 17:06GMTΒι¶ΉΤΌΕΔ World Service Australasia
- Fri 24 Aug 2018 23:06GMTΒι¶ΉΤΌΕΔ World Service except News Internet
- Sat 25 Aug 2018 03:06GMTΒι¶ΉΤΌΕΔ World Service except Australasia & News Internet
- Sat 25 Aug 2018 11:06GMTΒι¶ΉΤΌΕΔ World Service except Americas and the Caribbean, East and Southern Africa, News Internet & West and Central Africa
The Real Story Podcast
Subscribe via your favourite podcast app...
Podcast
-
The Real Story
Global experts and decision makers discuss, debate and analyse a key news story.